TrianglePUBLICATIONS · 23940220
Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2013 Sep 20
- First author
- Moorman AV
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Moorman AV
- type
- Author
- name
- Robinson H
- type
- Author
- name
- Schwab C
- type
- Author
- name
- Richards SM
- type
- Author
- name
- Hancock J
- type
- Author
- name
- Mitchell CD
- type
- Author
- name
- Goulden N
- type
- Author
- name
- Vora A
- type
- Author
- name
- Harrison CJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Moorman AV
- type
- Author
- name
- Robinson H
- type
- Author
- name
- Schwab C
- type
- Author
- name
- Richards SM
- type
- Author
- name
- Hancock J
- type
- Author
- name
- Mitchell CD
- type
- Author
- name
- Goulden N
- type
- Author
- name
- Vora A
- type
- Author
- name
- Harrison CJ
- type
- Author
- bibliography ids
- nci-bib-aaf2771e32ee09e808d80d93
- book metadata
- content sha256
- 298ad205507c2c8ef1a5d49d00d3e2f984c9e47d785253c5812c6e3476fa9691
- document type
- citation
- dois
- 10.1200/JCO.2013.48.9377
- electronic publication date
- display
- 2013 Aug 12
- precision
- day
- year
- 2013
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:23940220
- immutable id
- pubmed:23940220@298ad205507c2c8ef1a5d49d00d3e2f984c9e47d785253c5812c6e3476fa9691
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 27
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3389-96
- volume
- 31
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 23940220
- provenance
- batch id
- 0a08f044391426feb8ef
- provider
- NCBI PubMed ESummary
- record sha256
- 34f43f7a7fbd2b748a208e25260920e7699462df9050baa46f4b090eca0bb1b7
- response sha256
- d94e6242343e5962374663e5e5f0191e7b595329228d2e360db95a280e588409
- retrieved at
- 2026-09-09T23:46:57.614689+00:00
- publication date
- display
- 2013 Sep 20
- precision
- day
- year
- 2013
- publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Risk-directed treatment intensification significantly reduces the risk of relapse among children and adolescents with acute lymphoblastic leukemia and intrachromosomal amplification of chromosome 21: a comparison of the MRC ALL97/99 and UKALL2003 trials.
Preserved source evidence · Independent clinical review pending · Not medical advice